Atheroembolic renal disease.
Atheroembolic renal disease develops when atheromatous aortic plaques rupture, releasing cholesterol crystals into the small renal arteries. Embolisation often affects other organs, such as the skin, gastrointestinal system, and brain. Although the disease can develop spontaneously, it usually develops after vascular surgery, catheterisation, or anticoagulation. The systemic nature of atheroembolism makes diagnosis difficult. The classic triad of a precipitating event, acute or subacute renal failure, and skin lesions, are strongly suggestive of the disorder. Eosinophilia further supports the diagnosis, usually confirmed by biopsy of an affected organ or by the fundoscopic finding of cholesterol crystals in the retinal circulation. Renal and patient prognosis are poor. Treatment is mostly preventive, based on avoidance of further precipitating factors, and symptomatic, aimed to the optimum treatment of hypertension and cardiac and renal failure. Statins, which stabilise atherosclerotic plaques, should be offered to all patients. Steroids might have a role in acute or subacute progressive forms with systemic inflammation.
Scolari
Francesco
F
Faculty of Medicine, University of Brescia, Brescia, Italy. fscolar@tin.it
Ravani
Pietro
P
D001018:Aortic Diseases / Q000150:complications*; D050197:Atherosclerosis / Q000150:complications*; D017023:Coronary Angiography / Q000009:adverse effects; D017700:Embolism, Cholesterol / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D051437:Renal Insufficiency / Q000175:diagnosis / Q000209:etiology*; D012307:Risk Factors